Bank of America’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,677
| Closed | -$973 | – | 6910 |
|
|
2025
Q4 | $973 | Buy |
1,677
+145
| +9% | +$58 | ﹤0.01% | 6463 |
|
|
2025
Q3 | $513 | Buy |
1,532
+63
| +4% | +$41 | ﹤0.01% | 7584 |
|
|
2025
Q2 | $2.42K | Sell |
1,469
-15,694
| -91% | -$20.4K | ﹤0.01% | 7408 |
|
|
2025
Q1 | $27.1K | Buy |
17,163
+15,672
| +1,051% | +$38.6K | ﹤0.01% | 6882 |
|
|
2024
Q4 | $5K | Sell |
1,491
-787
| -35% | -$2.06K | ﹤0.01% | 7095 |
|
|
2024
Q3 | $4.28K | Sell |
2,278
-28
| -1% | -$53 | ﹤0.01% | 7033 |
|
|
2024
Q2 | $4.54K | Buy |
2,306
+119
| +5% | +$297 | ﹤0.01% | 7028 |
|
|
2024
Q1 | $6.71K | Sell |
2,187
-598
| -21% | -$1.29K | ﹤0.01% | 6958 |
|
|
2023
Q4 | $6.49K | Sell |
2,785
-638
| -19% | -$1.99K | ﹤0.01% | 6967 |
|
|
2023
Q3 | $13.8K | Sell |
3,423
-777
| -19% | -$3.39K | ﹤0.01% | 6787 |
|
|
2023
Q2 | $17.2K | Sell |
4,200
-550
| -12% | -$2.93K | ﹤0.01% | 6743 |
|
|
2023
Q1 | $14.6K | Sell |
4,750
-184
| -4% | -$661 | ﹤0.01% | 6843 |
|
|
2022
Q4 | $13.3K | Buy |
4,934
+7
| +0.1% | +$28 | ﹤0.01% | 6854 |
|
|
2022
Q3 | $20K | Buy |
4,927
+70
| +1% | +$448 | ﹤0.01% | 7039 |
|
|
2022
Q2 | $34K | Sell |
4,857
-117
| -2% | -$982 | ﹤0.01% | 7003 |
|
|
2022
Q1 | $58K | Sell |
4,974
-1,838
| -27% | -$21.8K | ﹤0.01% | 7115 |
|
|
2021
Q4 | $125K | Buy |
6,812
+686
| +11% | +$14.7K | ﹤0.01% | 6771 |
|
|
2021
Q3 | $154K | Sell |
6,126
-2,164
| -26% | -$83.9K | ﹤0.01% | 6474 |
|
|
2021
Q2 | $524K | Buy |
8,290
+1,615
| +24% | +$128K | ﹤0.01% | 5388 |
|
|
2021
Q1 | $822K | Buy |
6,675
+339
| +5% | +$49.2K | ﹤0.01% | 5008 |
|
|
2020
Q4 | $721K | Sell |
6,336
-1,289
| -17% | -$162K | ﹤0.01% | 4754 |
|
|
2020
Q3 | $912K | Sell |
7,625
-287
| -4% | -$33.5K | ﹤0.01% | 4287 |
|
|
2020
Q2 | $986K | Buy |
7,912
+6,327
| +399% | +$857K | ﹤0.01% | 4123 |
|
|
2020
Q1 | $306K | Buy |
1,585
+511
| +48% | +$160K | ﹤0.01% | 4840 |
|
|
2019
Q4 | $358K | Buy |
1,074
+23
| +2% | +$7.67K | ﹤0.01% | 5244 |
|
|
2019
Q3 | $339K | Sell |
1,051
-25
| -2% | -$8.07K | ﹤0.01% | 5339 |
|
|
2019
Q2 | $464K | Buy |
1,076
+535
| +99% | +$265K | ﹤0.01% | 5118 |
|
|
2019
Q1 | $306K | Sell |
541
-45
| -8% | -$21.6K | ﹤0.01% | 5307 |
|
|
2018
Q4 | $173K | Buy |
586
+48
| +9% | +$21.5K | ﹤0.01% | 5615 |
|
|
2018
Q3 | $381K | Buy |
538
+496
| +1,181% | +$306K | ﹤0.01% | 5128 |
|
|
2018
Q2 | $25K | Buy |
42
+35
| +500% | +$27.2K | ﹤0.01% | 6438 |
|
|
2018
Q1 | $18K | Buy |
+7
| New | +$17K | ﹤0.01% | 6414 |
|
Other funds holding VYNE
AFM
NCM
LCM
SC
ACM
TC
B
KCA
